Tower Research Capital LLC (TRC) - CONCERT PHARMACEUTICALS INC ownership

CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 73 filers reported holding CONCERT PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of CONCERT PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$43
-99.7%
7,398
+261.4%
0.00%
Q3 2022$14,000
-88.6%
2,047
-93.0%
0.00%
-100.0%
Q2 2022$123,000
+46.4%
29,212
+16.8%
0.00%
+200.0%
Q1 2022$84,000
+90.9%
25,007
+82.7%
0.00%0.0%
Q4 2021$44,000
+300.0%
13,691
+311.8%
0.00%
Q3 2021$11,000
-59.3%
3,325
-47.2%
0.00%
-100.0%
Q2 2021$27,000
-49.1%
6,300
-41.1%
0.00%0.0%
Q1 2021$53,000
-23.2%
10,691
+95.6%
0.00%
-50.0%
Q4 2020$69,000
-76.8%
5,467
-81.9%
0.00%
-33.3%
Q3 2020$297,000
+482.4%
30,218
+490.9%
0.00%
+50.0%
Q2 2020$51,000
+1175.0%
5,114
+1150.4%
0.00%
Q4 2019$4,0000.0%409
-39.9%
0.00%
Q3 2019$4,000
+33.3%
681
+136.5%
0.00%
Q1 2019$3,000
-75.0%
288
-68.8%
0.00%
-100.0%
Q4 2018$12,000
-84.2%
923
-79.7%
0.00%
-75.0%
Q2 2018$76,000
+49.0%
4,537
+31.3%
0.00%0.0%
Q3 2017$51,000
+24.4%
3,456
-13.6%
0.00%0.0%
Q4 2016$41,000
+355.6%
3,998
+776.8%
0.00%
+300.0%
Q4 2015$9,000
-71.9%
456
-85.6%
0.00%
-75.0%
Q2 2014$32,000
+45.5%
3,169
+90.2%
0.00%
+33.3%
Q1 2014$22,0001,6660.00%
Other shareholders
CONCERT PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 2,610$620,000,0006.47%
Parkman Healthcare Partners LLC 1,124,072$4,732,0001.74%
Kynam Capital Management, LP 1,000,000$4,210,0001.08%
EAM Investors, LLC 850,647$3,581,0000.87%
BVF INC/IL 3,629,000$15,278,0000.74%
EAM Global Investors LLC 388,730$1,637,0000.40%
RA Capital Management 3,307,203$13,923,0000.37%
Nantahala Capital Management 1,659,840$6,988,0000.35%
AWM Investment Company, Inc. 504,661$2,125,0000.34%
INGALLS & SNYDER LLC 1,411,153$5,941,0000.31%
View complete list of CONCERT PHARMACEUTICALS INC shareholders